Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kura Oncology Inc KURA

Healthcare Biotechnology
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on precision medicine for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer signaling pathways. Its product candidates include Ziftomenib, Tipifarnib and KO-2806. Ziftomenib, is a potent, selective, reversible and oral small molecule inhibitor that... see more

Recent & Breaking News (NDAQ:KURA)

Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer and for KO-539 in AML at Upcoming AACR-NCI-EORTC International Conference

GlobeNewswire October 16, 2017

Mid-Afternoon Market Update: Crude Oil Down Over 3%; Zumiez Shares Gain Following Strong Results

Benzinga.com  September 8, 2017

10 Biggest Mid-Day Gainers For Friday

Benzinga.com  September 8, 2017

Mid-Day Market Update: American Outdoor Brands Drops After Downbeat Q1 Results; Kura Oncology Shares Surge

Benzinga.com  September 8, 2017

Mid-Morning Market Update: Markets Mostly Lower; Finisar Issues Weak Q2 Forecast

Benzinga.com  September 8, 2017

Kura Oncology Announces Positive Phase 2 Study for Tipifarnib in HRAS Mutant Head and Neck Cancer

GlobeNewswire September 7, 2017

Kura Oncology to Participate in Citi’s 12th Annual Biotech Conference

GlobeNewswire August 29, 2017

Kura Oncology Announces Commencement of Public Offering of Common Stock

GlobeNewswire August 9, 2017

Kura Oncology Reports Second Quarter 2017 Financial Results and Provides Update on Tipifarnib Phase 2 Study

GlobeNewswire August 7, 2017

Investor Network: Kura Oncology, Inc. to Host Earnings Call

Accesswire August 7, 2017

Kura Oncology to Report Second Quarter 2017 Financial Results

GlobeNewswire July 31, 2017

Kura Oncology Announces Issuance of U.S. Patent for Lead Product Candidate Tipifarnib in Head and Neck Cancer

GlobeNewswire July 18, 2017

Kura Oncology Establishes Collaboration with Foundation Medicine to Support Tipifarnib Development in HRAS Mutant Head and Neck Cancer

GlobeNewswire July 13, 2017

Kura Oncology Added to Russell 3000® Index

GlobeNewswire June 26, 2017

Kura Oncology Presents Preliminary Clinical and Preclinical Data for Tipifarnib in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

GlobeNewswire June 14, 2017

Kura Oncology Announces Data Presentations for Tipifarnib at the International Conference on Malignant Lymphoma and the European Hematology Association Annual Meeting

GlobeNewswire June 7, 2017

Kura Oncology to Participate in Two Upcoming Investor Conferences

GlobeNewswire May 30, 2017

Kura Oncology Reports First Quarter 2017 Operational and Financial Results

GlobeNewswire May 15, 2017

Investor Network: Kura Oncology, Inc. to Host Earnings Call

Accesswire May 15, 2017

Kura Oncology to Report First Quarter 2017 Financial Results

GlobeNewswire May 8, 2017